You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 2, 2025

Drug Price Trends for NDC 28595-0120


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 28595-0120

Drug NameNDCPrice/Unit ($)UnitDate
NITROGLYCERIN 400 MCG SPRAY 28595-0120-49 25.55455 GM 2025-03-19
NITROGLYCERIN 400 MCG SPRAY 28595-0120-12 14.99083 GM 2025-03-19
NITROGLYCERIN 400 MCG SPRAY 28595-0120-49 23.03088 GM 2025-02-19
NITROGLYCERIN 400 MCG SPRAY 28595-0120-12 14.27471 GM 2025-02-19
NITROGLYCERIN 400 MCG SPRAY 28595-0120-49 22.87429 GM 2025-01-22
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 5 of 5 entries

Best Wholesale Price for NDC 28595-0120

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
NITROGLYCERIN 0.4MG/SPRAY AEROSOL Allegis Holdings, LLC 28595-0120-12 12 73.13 6.09417 2023-08-15 - 2028-08-14 FSS
NITROGLYCERIN 0.4MG/SPRAY AEROSOL Allegis Holdings, LLC 28595-0120-12 12 45.84 3.82000 2024-01-01 - 2028-08-14 FSS
NITROGLYCERIN 0.4MG/SPRAY AEROSOL Allegis Holdings, LLC 28595-0120-49 4.9 39.20 8.00000 2024-01-01 - 2028-08-14 FSS
NITROGLYCERIN 0.4MG/SPRAY AEROSOL Allegis Holdings, LLC 28595-0120-49 4.9 22.91 4.67551 2023-08-15 - 2028-08-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 4 of 4 entries

Market Analysis and Price Projections for Nitroglycerin (NDC: 28595-0120)

Introduction

Nitroglycerin, a medication used to treat angina pectoris and other heart conditions, is available in various forms, including sprays, patches, and tablets. This analysis focuses on the nitroglycerin spray aerosol with the NDC code 28595-0120, manufactured by Allegis Holdings, LLC.

Current Market Pricing

As of the latest data, the average pharmacy acquisition cost for nitroglycerin 0.4mg/spray aerosol (NDC: 28595-0120) is around $3.82 to $8.00 per unit, depending on the packaging and vendor agreements[2].

Price Trends

  • Recent Pricing: The prices for nitroglycerin spray aerosol have shown some variability. For instance, as of 2024, the price per unit ranged from $3.82 to $8.00, indicating fluctuations that could be due to market competition, vendor negotiations, or changes in demand[2].
  • Historical Context: While specific historical data for this NDC is limited, generic drug prices generally tend to decrease over time due to increased competition. However, the initial entry of generics can sometimes lead to a period of price stability before further reductions occur[4].

Market Drivers

  • Generic Competition: The presence of multiple generic versions of nitroglycerin can drive prices down. The entry of new generics, especially after the expiration of patent exclusivity periods, often leads to significant price reductions[4].
  • Demand and Supply: The demand for nitroglycerin remains steady due to its use in managing chronic conditions like angina. However, supply chain dynamics and manufacturing costs can influence pricing.

Forecast and Projections

  • Short-Term Projections: In the short term, prices are likely to remain relatively stable or see minor reductions as the market adjusts to current supply and demand conditions. Any significant price drops would likely be driven by new generic entries or changes in vendor agreements[2].
  • Long-Term Projections: Over the long term, the trend for generic drugs is generally towards lower prices. As more generics enter the market and competition increases, prices for nitroglycerin spray aerosol are expected to decrease. For example, the FDA has noted that subsequent generic approvals can lead to substantial price reductions, often resulting in savings of over 50% compared to the branded version[4].

Impact of Regulatory Changes

  • Medicare Drug Price Negotiation Program: While the Medicare Drug Price Negotiation Program primarily targets high-cost brand-name drugs, it sets a precedent for price negotiations in the pharmaceutical market. This could indirectly influence pricing strategies for all drugs, including generics like nitroglycerin, by promoting a culture of price transparency and negotiation[5].

Competitive Landscape

  • Market Share: The nitroglycerin market is shared among several manufacturers, including Allegis Holdings, LLC, and other generic drug producers. The market share can shift based on pricing strategies, product availability, and regulatory approvals[2].
  • New Entrants: The entry of new generic manufacturers can further reduce prices. For instance, the approval of new ANDAs (Abbreviated New Drug Applications) for nitroglycerin could lead to increased competition and lower prices[4].

Unmet Needs and Opportunities

  • Patient Access: One of the significant unmet needs is ensuring affordable access to medications like nitroglycerin. Lower prices driven by generic competition can improve patient access and adherence to treatment plans.
  • Innovative Delivery Systems: There is an opportunity for manufacturers to develop innovative delivery systems or formulations that could differentiate their products and potentially command a premium price, although this would need to balance with the overall cost sensitivity of the market.

Key Takeaways

  • Price Stability: Short-term prices for nitroglycerin spray aerosol are expected to remain relatively stable.
  • Long-Term Reductions: Long-term prices are likely to decrease due to increased generic competition.
  • Regulatory Influence: Regulatory changes, such as the Medicare Drug Price Negotiation Program, may indirectly influence pricing strategies.
  • Market Competition: The entry of new generic manufacturers will continue to drive prices down.

FAQs

Q: What is the current average price for nitroglycerin 0.4mg/spray aerosol (NDC: 28595-0120)? A: The current average price ranges from $3.82 to $8.00 per unit, depending on the packaging and vendor agreements[2].

Q: How does generic competition affect the price of nitroglycerin? A: Generic competition typically drives prices down. The entry of new generics, especially after patent exclusivity periods expire, often leads to significant price reductions[4].

Q: What impact could the Medicare Drug Price Negotiation Program have on nitroglycerin prices? A: While the program primarily targets high-cost brand-name drugs, it promotes price transparency and negotiation, which could indirectly influence pricing strategies for all drugs, including generics like nitroglycerin[5].

Q: Are there any new entrants expected in the nitroglycerin market? A: Yes, the approval of new ANDAs for nitroglycerin could lead to increased competition and lower prices[4].

Q: How can manufacturers differentiate their nitroglycerin products in a competitive market? A: Manufacturers can develop innovative delivery systems or formulations to differentiate their products, although this must be balanced with cost sensitivity[2].

Sources

  1. Prescription Drug Price Transparency Results and Recommendations - Oregon Department of Consumer and Business Services[1].
  2. Pharmaceutical drug prices and trends for nitroglycerin - Drug Patent Watch[2].
  3. NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025 - Drug Development & Delivery[3].
  4. Estimating Cost Savings from New Generic Drug Approvals in 2018 - FDA[4].
  5. Medicare Drug Price Negotiation Program - CMS[5].

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.